![]() |
Trials |
A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant MelanomaCancer type: Melanoma Phase: I Principal Investigator: Nyakas Martha Country: NO Keywords: Norway, Oslo University Hospital, BRAF mutant, BRAF mutated, melanoma, metastatic, Oslo Status: Completed Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01436656?term=CLGX818X2101&rank=1 |